Validation of a 3-h Sampling Interval to Assess Variability in Cytochrome P450 3A Phenotype and the Impact of Induction and Mechanism-Based Inhibition Using Midazolam as a Probe Substrate

Background: Drug probe phenotyping is used extensively in academic and industry research to evaluate cytochrome P450 (CYP) phenotype in order to account for sources of between- and within- subject variability in metabolic clearance. In terms of application, CYP3A is the most important drug metaboliz...

Descripción completa

Detalles Bibliográficos
Autores principales: van Dyk, Madelé, Kapetas, Asha J., Hopkins, Ashley M., Rodrigues, A. David, Vourvahis, Manoli, Sorich, Michael J., Rowland, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777419/
https://www.ncbi.nlm.nih.gov/pubmed/31611799
http://dx.doi.org/10.3389/fphar.2019.01120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777419/
https://www.ncbi.nlm.nih.gov/pubmed/31611799
http://dx.doi.org/10.3389/fphar.2019.01120

Ejemplares similares